Release and bioactivity of PACA nanoparticles containing D-Lys 6-GnRH for brushtail possum fertility control

Journal of Controlled Release

Volumn 149, Issue 3, 2011, Pages 307-313

  Kafka, Alexandra P ^a,c   McLeod, Bernie J ^b   Rades, Thomas ^a   McDowell, Arlene ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b INVERMAY AGRICULTURAL CENTRE   (New Zealand)

^c Coriolis Pharma ^*  (Germany)

Author keywords

Brushtail possum; Fertility control; GnRH; Oral delivery; PACA nanoparticles; Peptide polymer conjugates

Indexed keywords

BRUSHTAIL POSSUM; FERTILITY CONTROL; GNRH; ORAL DELIVERY; PACA NANOPARTICLES;

BIOCONTROL; MOLECULAR BIOLOGY; PEPTIDES; POLYMERS;

NANOPARTICLES;

DEXTRO LYSINE 6 GONADORELIN; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; LUTEINIZING HORMONE; NANOPARTICLE; PEPTIDE; POLY(ETHYLCYANOACRYLATE) NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; BIRTH CONTROL; BRUSHTAIL POSSUM; CECUM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG UPTAKE; ENDOCYTOSIS; HORMONE RESPONSE; HYPOPHYSIS; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLUID; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MARSUPIAL; NEW ZEALAND; NONHUMAN; PLASMA; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; STOMACH JUICE; SYSTEMIC CIRCULATION;

ANIMALS; CONTRACEPTIVE AGENTS; CYANOACRYLATES; FERTILITY; GONADOTROPIN-RELEASING HORMONE; LUTEINIZING HORMONE; MALE; MARSUPIALIA; NANOPARTICLES; NEW ZEALAND;

EID: 79951947663     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.10.029     Document Type: Article

References (47)

1. P. Cowan, Biological control of possums: Prospects for the future, in: T.L. Montague (Ed.), The Brushtail Possum: Biology, Impact and Management of an Introduced Marsupial, Manaaki Whenua Press Lincoln, New Zealand, 2000, pp. 262-270.
2. P.E. Cowan, Possum biocontrol: Prospects for fertility regulation, Reprod. Fertil. Dev. 8 (1996) 655-660. (Pubitemid 26288039)
3. A. McDowell, B.J. McLeod, T. Rades, I.G. Tucker, Application of pharmaceutical drug delivery for biological control of the common brushtail possum in New Zealand: A review, Wildl. Res. 33 (2006) 679-689.
4. K. Sabeur, B.A. Ball, T.M. Nett, H.H. Ball, I.K.M. Liu, Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs, Reproduction 125 (2003) 801-806. (Pubitemid 36722548)
5. B. Gilna, D.B. Lindenmayer, K.L. Viggers, Dangers of New Zealand possum biocontrol research to endogenous Australian fauna, Conserv. Biol. 19 (2005) 2030-2032.
6. U.B. Mayr, P. Walcher, C. Azimpour, E. Riedmann, C. Haller, W. Lubitz, Bacterial ghosts as antigen delivery vehicles, Adv. Drug Deliv. Rev. 57 (2005) 1381-1391. (Pubitemid 40791117)
7. K. Jalava, A. Hensel, M. Szostak, S. Resch, W. Lubitz, Bacterial ghosts as vaccine candidates for veterinary applications, J. Control. Release 85 (2002) 17-25. (Pubitemid 35452635)
8. A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, V. Preat, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach, J. Control. Release 116 (2006) 1-27.
9. C. Damge, C. Michel, M. Aprahamian, P. Couvreur, J.P. Devissaguet, Nanocapsules as carriers for oral peptide delivery, J. Control. Release 13 (1990) 233-239. (Pubitemid 20313521)
10. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, C. Vauthier, Nanocapsule technology: A review, Crit. Rev. Ther. Drug 19 (2002) 99-134.
11. A. Graf, A. McDowell, T. Rades, Poly(alkycyanoacrylate) nanoparticles for enhanced delivery of therapeutics: Is there real potential? Expert Opin. Drug Deliv. 6 (2009) 371-387.
12. C. Vauthier, P. Couvreur, Developing nanoparticle drug carriers, Pharm. Technol. Eur. 19 (2007) 35-42. (Pubitemid 46117290)
13. H. Vranckx, M. Demoustier, M. Deleers, A new nanocapsule formulation with hydrophilic core: Application to the oral administration of salmon calcitonin in rats, Eur. J. Pharm. Biopharm. 42 (1996) 345-347. (Pubitemid 26384371)
14. S. Watnasirichaikul, T. Rades, I.G. Tucker, N.M. Davies, In vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion, J. Pharm. Pharmacol. 54 (2002) 473-480.
15. S. Watnasirichaikul, N.M. Davies, T. Rades, I.G. Tucker, Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions, Pharm. Res. 17 (2000) 684-689.
16. A. McDowell, B.J. McLeod, T. Rades, I.G. Tucker, Polymeric nanoparticles as an oral delivery system for biocontrol agents for the brushtail possum (Trichosurus vulpecula), NZ Vet. J. 57 (2009) 370-377.
17. S. Gibaud, C. Rousseau, C. Weingarten, R. Favier, L. Douay, J.P. Andreux, P. Couvreur, Poly(alkylcyanoacrylate) nanoparticles as carriers for granulocytecolony stimulating factor (G-CSF), J. Control. Release 52 (1998) 131-139. (Pubitemid 28123180)
18. C. Tasset, N. Barette, S. Thysman, J.M. Ketelslegers, D. Lemoine, V. Preat, Poly (isobutylcyanoacrylate) nanoparticles as sustained-release system for calcitonin, J. Control. Release 33 (1995) 23-30.
19. A.P. Kafka, T. Kleffmann, T. Rades, A. McDowell, Characterization of peptide polymer interactions in poly(alkylcyanoacrylate) nanoparticles: A mass spectrometric approach, Curr. Drug Deliv. 7 (2010) 208-215.
20. 6-GnRH: Potential for copolymerization in polymeric nanoparticles, Mol. Pharm. 6 (2009) 1483-1491.
21. J.L. Grangier, M. Puygrenier, J.C. Gautier, P. Couvreur, Nanoparticles as carriers for growth-hormone releasing-factor, J. Control. Release 15 (1991) 3-13.
22. A.M. Hillery, I. Toth, A.T. Florence, Co-polymerized peptide particles 2: Oral uptake of a novel co-polymeric nanoparticulate delivery system for peptides, J. Control. Release 42 (1996) 65-73. (Pubitemid 26297877)
23. A.M. Padula, GnRH analogues: Agonists and antagonists, Anim. Reprod. Sci. 88 (2005) 115-126.
24. A. McDowell, J.J. Nicoll, B.J. McLeod, I.G. Tucker, N.M. Davies, Gastrointestinal transit in the common brushtail possum measured by gamma scintigraphy, Int. J. Pharm. 302 (2005) 125-132.
25. A.P. Kafka, T. Rades, A. McDowell, Rapid and specific high-performance liquid chromatography for the in vitro quantification of D-Lys6-GnRH in a microemulsiontype formulation in the presence of peptide oxidation products, Biomed. Chromatogr. 24 (2010) 132-139.
26. K. Biemann, Nomenclature for peptide fragment ions (positive-ions), Method Enzymol. 193 (1990) 886-887.
27. L.G. Moore, W.N. Chie, S. Lun, S.B. Lawrence, D.A. Heath, K.P. McNatty, Isolation, characterization and radioimmunoassay of luteinizing hormone in the brushtail possum, Reprod. Fert. Develop. 9 (1997) 419-425.
28. 131I-labelled human growth hormone of high specific radioactivity, Biochem. J. 89 (1963) 114-123.
29. M. Aboubakar, P. Couvreur, H. Pinto-Alphandary, B. Gouritin, B. Lacour, R. Farinotti, F. Puisieux, C. Vauthier, Insulin-loaded nanocapsules for oral administration: In vitro and in vivo investigation, Drug Develop. Res. 49 (2000) 109-117.
30. M. Liang, N.M. Davies, I. Toth, Increasing entrapment of peptides within poly (alkylcyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization, Int. J. Pharm. 362 (2008) 141-146.
31. D. Scherer, J.R. Robinson, J. Kreuter, Influence of enzymes on the stability of poly (butylcyanoacrylate) nanoparticles, Int. J. Pharm. 101 (1994) 165-168.
32. H.Y. Karasulu, Microemulsions as novel drug carriers: The formation, stability, applications and toxicity, Expert Opin. Drug Deliv. 5 (2008) 119-135. (Pubitemid 351234113)
33. S.T. Dogru, S. Calis, F. Oner, Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: In vitro/in vivo evaluation, J. Clin. Pharm. Ther. 25 (2000) 435-443. (Pubitemid 32055601)
34. R.H. Mueller, C. Lherm, J. Herbort, T. Blunk, P. Couvreur, Alkylcyanoacrylate drug carriers I: Physicochemical characterization of nanoparticles with different alkyl chain length, Int. J. Pharm. 84 (1992) 1-11.
35. A.M. Hillery, I. Toth, A.J. Shaw, A.T. Florence, Co-polymerised peptide particles (CPP)1: Synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system, J. Control. Release 41 (1996) 271-281.
36. T.W. Redding, A.J. Kastin, D. Gonzalez, D.H. Coy, E.J. Coy, D.S. Schalch, A.V. Schally, Half-life, metabolism and excretion of tritiated luteinizing hormone-releasing hormone (LHRH) in man, J. Clin. Endocrinol. Metab. 37 (1973) 626-631.
37. D.J. Handelsman, R.S. Swerdloff, Pharmacokinetics of gonadotropin- releasing hormone and its analogs, Endocr. Rev. 7 (1986) 95-105.
38. B.J. McLeod, H. Zhang, L. Huang, E.G. Thompson, A.G. Butt, I.G. Tucker, An in situ single-pass perfusion model for assessing absorption across the intestinal mucosa of the brushtail possum, NZ Vet. J. 53 (2005) 234-241. (Pubitemid 41098156)
39. J.D.A. Tyndall, R. Sandilya, GPCR agonists and antagonists in the clinic, Med. Chem. 1 (2005) 405-421.
40. P. Couvreur, B. Kante, M. Roland, P. Speiser, Adsorption of antineoplastic drugs to poly(alkylcyanoacrylate) nanoparticles and their release in calf serum, J. Pharm. Sci. 68 (1979) 1521-1524.
41. J. Eymann, C.A. Herbert, B.P. Thomson, T.E. Trigg, D.W. Cooper, D.C. Eckery, Effects of deslorelin implants on reproduction in the common brushtail possum (Trichosurus vulpecula), Reprod. Fertil. Develop. 19 (2007) 899-909.
42. A. Yamamoto, T. Taniguchi, K. Rikyuu, T. Tsuji, T. Fujita, M. Murakami, S. Muranishi, Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats, Pharm. Res. 11 (1994) 1496-1500.
43. H. Tozaki, Y. Emi, E. Horisaka, T. Fujita, A. Yamamoto, S. Muranishi, Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: Implications in peptide delivery to the colon, J. Pharm. Pharmacol. 49 (1997) 164-168.
44. J.Y. Wen, R. Ledger, B.J. McLeod, N.M. Davies, A.G. Butt, I.G. Tucker, Protein and peptide degradation of the common brushtail possum in the intestine (Trichosurus vulpecula), J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 172 (2002) 553-559.
45. J.Y. Wen, R. Ledger, A.G. Butt, B.J. McLeod, N.M. Davies, I.G. Tucker, Inhibition of proteolysis in luminal extracts from the intestine of the brushtail possum, J. Pharm. Pharmacol. 54 (2002) 1365-1372.
46. S. Rahimipour, N. Ben-Aroya, M. Fridkin, Y. Koch, Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone, J. Med. Chem. 44 (2001) 3645-3652. (Pubitemid 33026672)
47. C.A. Herbert, T.E. Trigg, M.B. Renfree, G. Shaw, D.C. Eckery, D.W. Cooper, Effects of a gonadotropin-releasing hormone agonist implant on reproduction in a male marsupial, Macropus eugenii, Biol. Reprod. 70 (2004) 1836-1842. (Pubitemid 38715642)